In a new study, researchers at the University of Oregon’s Phil and Penny Knight Campus for Accelerating Scientific Impact used start codon disruption with CRISPR-Cas9 gene editing to prevent Fuchs’ corneal dystrophy in mice.
Start codon disruption with CRISPR-Cas9 gene editing prevents Fuchs’ corneal dystrophy in mice
